Evidence map›Paper›PMID 39192930›Full record

ArticleCureus2024

Myxoid Pleomorphic Liposarcoma of the Spermatic Cord: A Rare Entity at a Rare Site.

Yazhini Chandrasekaran, Kalaivani Amitkumar, Ashwini Elamaran, Muthu Sudalaimuthu, Subhalakshmi Kumaran

Abstract readCase Reports
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Liposarcoma: State of the Art-A Scoping Review.Medical sciences (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yazhini ChandrasekaranDepartment of Pathology, Sri Ramaswamy Memorial (SRM) Institute of Science and Technology, Chengalpattu, IND.
Kalaivani AmitkumarDepartment of Pathology, Sri Ramaswamy Memorial (SRM) Institute of Science and Technology, Chengalpattu, IND.
Ashwini ElamaranDepartment of Pathology, Sri Ramaswamy Memorial (SRM) Institute of Science and Technology, Chengalpattu, IND.
Muthu SudalaimuthuDepartment of Pathology, Sri Ramaswamy Memorial (SRM) Institute of Science and Technology, Chengalpattu, IND.
Subhalakshmi KumaranDepartment of Radiology, Sri Ramaswamy Memorial (SRM) Institute of Science and Technology, Chengalpattu, IND.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Myxoid pleomorphic liposarcoma (MPLPS) is an extremely rare entity that has been recognized and included in the literature recently. Liposarcomas are adipocytic tumors that are usually located in the extremities and retroperitoneum. Paratesticular liposarcomas are extremely rare malignant tumors originating from the adipose tissue of the paratesticular region. Myxoid pleomorphic liposarcoma (MPLPS) is an exceedingly rare variant of liposarcoma, with very few cases reported in the literature so far. Mediastinum is the most common site for MPLPS followed by the limbs, head, and neck. We report a case of a 50-year-old male patient who presented with a swelling in the right inguinal region, which came to the patient's attention in the past month. After investigations, a right-high orchidectomy was done. Histopathological examination and immunohistochemistry were performed and a diagnosis of myxoid pleomorphic liposarcoma (MPLPS) involving the spermatic cord was made. So here we report this case of myxoid pleomorphic liposarcoma involving the spermatic cord for the first time in the literature.

Indexed as

adipocytic tumorsliposarcomaliposarcoma of spermatic cordmyxoid pleomorphic liposarcomaparatesticular tumors

Identifiers

PMID39192930
PMCPMC11347961

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.